HealthcareResearchInsights: December 2022

Thursday, December 22, 2022

Pregnancy Test Kits Market 2022: Size, Share, Drivers, Restraints, Analysis and Forecast-2030

Pregnancy Test Kits Market

The pregnancy test kits market size is expected to reach USD 1.94 billion by 2030 at 5.17% CAGR during the forecast period 2022-2030

The Pregnancy test kits market has been evaluated as average growing market and expected that the market will reach high growth figures in coming years. A factsheet published by the WHO states that about 40% of pregnancy cases reported each year were unintended and around 10% cases were that of teenage pregnancies and the number is expected to increase further in the coming years. These are the main reasons leading to the market growth of pregnancy test kits market. Other factors such as the increasing awareness about the availability of pregnancy test kits with their clinically proven safety and effectiveness has resulted in an increasing demand for self-detecting pregnancy kits thereby increasing the growth and size of global pregnancy test kits market. Moreover, the escalating adolescent pregnancy rate, promotional campaigns undertaken by manufacturers of these pregnancy test or recognition kits is driving the growth of pregnancy test kits market.

North America holds the first rank in global pregnancy test kit market during the forecasted period. The market in the region is likely to elaborate at a CAGR of 3.8% over the next few years. Higher expenditure on healthcare sector is expected to be a major growth driver of North America pregnancy test kit market. Western Europe pregnancy test kit market is also anticipated to witness a promising growth sparked by rising adoption of digital pregnancy test kit devices in the region. Asia-Pacific pregnancy test kit market is expected to observe a highest CAGR during the forecast period. Speedily expanding population in the region, rising per capita pay and growing urbanization are some of the major issues which are projected to strengthen pregnancy test kit market in countries such as India and China.

Major Key Players:

Key players profiled in the report are Alere Inc. (US), Prestige Brands Holdings, Inc, (US), Quidel Corporation (US), Procter & Gamble Co., (Germany), Piramal Enterprises (India), Cardinal Health (US), and Confirm Biosciences (US).

Market Segmentation

The global pregnancy kits market is segmented on the basis of type of test, product and end users. Based on the type of test, the market has been segmented as blood test for HCG, Urine test for HCG and others. Based on products, the market has been segmented into digital devices, line indicators which are further segmented into strips, cassettes and mid-stream devices and others. Further on the basis of end users the market has been segmented as hospitals, clinics, households and others. The home pregnancy test segment is growing at a rapid pace due to technological progressions and arresting product features with major organizations such as Alere Inc, Prestige Brands Holding Inc, and Procter & Gamble etc playing the key role in the launching of new and innovative home pregnancy test kits. Also the market has been growing due to the reasons such as some of the home pregnancy test kits have 99% exactness rate in detecting HCG levels from the day of the expected period of women undertaking the test. The HCG urine test accounts for the largest pregnancy test market share as per alleged pregnancy test market capturing nearly 43% of the revenues shared in 2016. There is an increasing inclination for conventional laboratory tests resulting in the decline of other test types such as FSH Urine test, HCG blood test, and LH urine test.

Regional Analysis

The regional segmentation of the global pregnancy test strips market North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). The lion's share in this market belongs to North America, and this share is expected to grow during the forecast period. Reasons for the growth of this market include increasing pool of aware females, need for household determination of pregnancy, and investment regarding the advancement of pregnancy test kits. Biggest share in the North American market is controlled by the United States of America (USA). Many key players in this market are also based in the USA.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Saudi Arabia Medical Devices Market, Size, Share, Growth, Business Risk & Industry Analysis Reports 2030

Saudi Arabia Medical Devices Market

A medical device is any instrument, appliance including any software, biologic or non-biologic material, to be used for the diagnostic or therapeutic use for management of diseases and disorders.

Saudi Arabia Medical Devices Market is anticipated to reach USD 3,100 Million by 2030 at 5.80% CAGR during the forecast period 2022-2030

The medical device industry witnessed one of the fastest growth propelled by innovation and rapid uptake of technologies. The medical devices industry has also resulted in the successful fusion of information technology and healthcare. Technology and product development remain the main pillars for the growing market for medical devices. The market involves two segments one high-tech devices with extreme sophistication and another is the low tech improved devices. The high tech segment such as diagnostic imaging devices is witnessing higher rates of growth. The low tech segment is also growing at a good rate but has witnessed growth in developing regions as the market for these in developed regions is stagnant. The other market driving factors are rising public healthcare expenditure in Saudi Arabia, development of large hospitals such as King Faisal hospital in Riyadh, demand for noninvasive therapy etc.

The market constraints are strict and ambiguous regulatory framework, growing concern for security especially data security, differential availability between developed and developing regions, connectivity issues in Saudi Arabia, the interference Sharia courts etc.

The future developments will include cloud integration, connected healthcare devices and growing demand for personalized medical wearable devices. Healthcare mobile applications will also lead the market.

Major Key Players:

The major participants of this market are: Johnson & Johnson, General Electric, Medtronic, Koninklijke Philips Electronics NV., Baxter Internationa, Fresenius Medical Care AG & Co., Cardinal Health, Al-Salehiya Medical Estableshment, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Al Amin Medical Instruments Company (AMICO), Al Faisaliah Medical Systems (FMS), Siemens Ltd and others.

Market Segmentation

Saudi Arabia medical devices market has been segmented on the basis of product type which comprises monitoring devices, diagnostic devices, diagnostic molecular devices, drug delivery devices, surgical devices, bio implants and stimulation devices, automation and robotics, electromedical devices and others. On the basis of therapeutic application; market is segmented into general surgery, diagnostic imaging, respiratory, orthopedics, cardiovascular, dental, neurology, ophthalmology, ear-nose-throat (ENT), nephrology and urology, and others. On the basis of end users; market is segmented hospitals, ambulatory, home and others.

Regional Analysis

The healthcare sector of Saudi Arabia is divided between private and state. The public healthcare expenditure accounts for approximately 75% of total health expenditure in 2014. Local manufacturing represents a poor outlook which is limited to consumables and ordinary articles. The government has established some of the best hospitals in the region such as King Faisal specialist hospital and research center, Riyadh military hospital, Saudi Arabia’s National Guard health affairs hospital etc. Saudi Arabia is extremely dependent on imports for medical devices and imports account for approximately 92% of total market for medical devices. U.S. medical device suppliers dominate the scenario with European vendors in the second position. Among the regions of Saudi Arabia Riyadh tops the healthcare expenditure list followed by Tabuk, Makkah and Madina.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Antipsychotic Drugs Market report predicts impressive growth by 2030 just published

Antipsychotic Drugs Market

Anti-psychotics are drugs used in the treatment of psychosis which are a group of disorders characterized by serious distortion of thought, behavior, recognition of reality and perception, delusions and hallucinations.

Antipsychotic Drugs Market is expected to register a CAGR of 5.7% to reach USD 33.59 Billion by 2030

The market for psychotics represents a huge potential as can be seen from the following estimates by World Health Organization (WHO)

Depression affects an estimated 300 million people in the world.

Bipolar affective disorder takes a toll on about 60 million people worldwide.

Schizophrenia, a severe mental disorder, affects about 21 million people worldwide.

Dementia has a prevalence in about 47.5 million people worldwide

One fourth of people are affected by mental or neurological disorders at some point in their lives.

Thus the current number of untapped patients are of an order of around 450 million. Other market drivers are growing awareness and focus on mental illness, inclusion of more conditions such as learning disability in the mental disorders segment, rise of geriatrics population and mental hospitals etc.

The market constraints are social stigma and discrimination, poor efficacy and efficiency of anti-psychotic drugs, serious side effects such as habit forming potential etc. Patent expiry is also constraining the market as a number of established brands such as, Zyprexa, Seroquel, Risperdal lost patents. The drug development pipeline represents another miserable situation. The development pipeline is poor with a few if any novel acting drugs. The market represents numerous drugs with same mechanism of action and similar therapeutic profile which has hampered the market. Strict regulatory framework is another barrier along with the technical difficulties with performing clinical trials for these class of drugs as it is difficult to separate cause and effect in case of anti-psychotic drugs.

Major Key Players:

The major participants of this market are: Eli Lilly & Co., Bristol-Myers Squibb, AstraZeneca, Pfizer Inc., GlaxoSmithKline Plc., Johnson & Johnson and others.

Segment Analysis

Market Research Future report offers an all-inclusive segmental analysis of the antipsychotic drugs market on the basis of application and generation.

Based on therapeutic application, it is segmented into injectable antipsychotics dementia, depression, bipolar disorder, schizophrenia and others. Of these, psychotic depression and schizophrenia will have the largest share in the antipsychotic drugs market over the predicted years.

Based on generation, the antipsychotic drugs market is segmented into first, second, third. The first generation is also called neuroleptics or typical antipsychotics and the second generation is also called atypical antipsychotics.

Regional Analysis

Based on region, the antipsychotic drugs market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, the American region will have precedence in the market over the predicted years owing to excellent support from the government, better regulatory framework, well-established healthcare infrastructure, good reimbursement scenario especially in the US and rapid uptake of novel drug molecules. Europe will grab the second largest share in the antipsychotic drugs market owing to increasing healthcare expenditure made by the government coupled with increasing disposable income. The antipsychotic drugs market in the Asia Pacific region will grow at the fastest rate and at a healthy CAGR owing to increasing social awareness concerning psychotic disorders and also other associated disorders namely depression, anxiety and mania. Moreover, the accessibility of medicines to treat mental illness will boost the growth of the antipsychotic drugs market in this region over the predicted years.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Obesity Managements Market: Industry Analysis, Opportunity and Forecast to 2030

Obesity Managements Market

The obesity management market size is projected to expand at 9.20% CAGR to reach USD 268.7 billion during the forecast period 2022-2030.

According to World Health Organization (WHO), the worldwide prevalence of obesity nearly doubled between 1980 and 2008. According to country estimates for 2008, over 50% of both men and women in the WHO European Region were overweight, and roughly 23% of women and 20% of men were obese. It is the cause of many health problems, such as obesity, heart disease, and certain cancers. Obesity leads to short- and long-term health problems for mother and her child, if she is excess weight during pregnancy.

Companies are continuously engaged in research and development process along with well know research institute for developing the best treatment of obesity and leads the market. In 2015, researchers at the University of Liverpool, working with a global health care company, have helped introduce a new treatment for obesity. After conducting the research it was found that the treatment which is a once-daily injectable derivative of a metabolic hormone called GLP-1 normally used in the type 2 obesity treatment, has proved that it help non diabetic patients in weight loss. These development help company to provide the best option for the treatment and capture the maximum share of global market.

Major Key Players:

Pfizer Inc. (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (U.K), AstraZeneca plc (U.K), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of Obesity Management, globally.

Regional Analysis

The market of obesity management is growing rapidly in Asia Pacific region, owing to poor diet, lack of physical activity, and unhealthy life balance. These are the factor which leads the obesity population in this region. Most of the countries of this region have common lifestyle and economic conditions, So the factor introduce above have common with in this region and leads the patient population. Government of developing countries within this region are more focusing towards new technology and advance treatment option, thus more research and development programs are initiated for the development of new drugs. These are the factors which are fuelling the growth of the market of obesity managements with the significant rates. These advance treatment will overcome the saturation that occurs during last few years. Countries like India and china are more focused market for global market players owing to huge patient population and growing purchasing power as compare to other countries in this region. The market of obesity management is much higher in the Americas region attribute to high presence of obesity population along with developed treatment option. According to CDC, 37.9% of adults over 20 years were suffering with the obesity between 2013 and 2014 and 70.7% of adults aged 20 years and over were suffering with overweight, including obesity. These stats show the opportunity of market players within the Americas region.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Bariatric Surgery Devices Market Forecast to 2030 Detailed in New Research Report

Bariatric Surgery Devices Market

The Bariatric Surgery Devices Market will obtain a CAGR of 6.10 % and USD 3,282.27 million in the forecast period by 2030.

Bariatric surgery involves making changes to the digestive system to help the patient lose weight

The bariatric surgery devices market is expected to be driven by the increasing prevalence of obesity, rising technological advancements, a growing number of bariatric & metabolic surgeries, and the increasing number of regulatory approvals for bariatric surgery devices. However, factors such as rising product recall in the industry and high cost of bariatric surgeries are expected to restrict the market growth during the forecast period. On the other hand, emerging markets with a high prevalence of obesity are expected to offer high growth opportunities in the market.

Major Key Players:

MRFR recognizes the following companies as the Key Players in the global bariatric surgery devices market— Medtronic (Ireland), Apollo Endosurgery, Inc. (US), Intuitive Surgical Inc. (US), Johnson & Johnson Services Inc. (US), ReShape Lifesciences, Inc. (US), Olympus Corporation (Japan), Mediflex Surgical Products (US), TransEnterix Surgical, Inc. (US), Aspire Bariatrics (US), and Spatz FGIA, Inc. (US) among others.

Segment Analysis

The global surgery instruments market is segmented into type, procedure, and end user. By type, the market has been segmented into minimally invasive surgical devices and non-invasive surgical devices. The minimally invasive surgical devices are further sub-segmented into stapling devices, energy/vessel sealing devices, suturing devices and accessories. Based on procedure, the market has been segmented into sleeve gastrectomy, gastric bypass, revision surgery, adjustable gastric band, and others. On the basis of end user, the market has been segmented into hospitals, specialty centers, ambulatory surgical centers, and others.

Regional Analysis

The global bariatric surgery devices market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest share of the global bariatric surgery devices market. This is owing to the rising obese and overweight population, increasing sedentary lifestyle, and growing demand for minimally invasive procedures. Also, increasing awareness about procedures related to bariatric surgery devices in the US, prompts market growth.

The European market holds the second-largest position in the global bariatric surgery devices market. Factors attributing to the growth of the market are the availability of minimally invasive bariatric surgery devices, the increasing launch of bariatric surgery devices and growing innovation in the medical device market is expected to drive the market growth in Europe.

Asia-Pacific is estimated to be the fastest-growing region owing to the rapidly rising per capita disposable income and availability of advanced surgical devices support the market growth. Also, the presence of a large target population in countries such as China and India are expected to boost the market growth. The growing geriatric population in Asian countries is also likely to be one of the major supporting factors during the forecast period.

The bariatric surgery devices market in the Middle East & Africa is expected to grow at a significant rate owing to growing advanced treatment facilities in the economies of the UAE and Saudi Arabia in the Middle East which drives market growth.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hyperspectral Imaging System Market Forecast to 2030 Available in New Report

Hyperspectral Imaging System Market

The Hyperspectral Imaging System Market is projected to reach USD 15582.37 Million by 2030 at 18.10% CAGR during the forecast period 2022-2030.

Hyperspectral imaging system has wide applications in areas such as art conservation, vegetation, water resource control, archaeology, food quality, forensic medicine, crime scene detection, and forensic medicine. HSI technology is mainly used by the defense sector, government agencies, and non-military application sectors such as agriculture and mineral.

The growth of the global hyperspectral imaging system market is boosted by various factors such as the growing industrial applications of hyperspectral imaging, Technological advancements in electronics industry, such as sensor design, high spectral resolution, high spatial resolution, compact and lightweight devices, growing prevalence of cancer, and increasing awareness of innovative diagnostics methods.

Additionally, the introduction of innovative products in the market is expected to drive the growth of the market during the forecast period. For instance, In January 2020, Specim, Spectral Imaging Ltd. (Finland), launched Specim’s new AFX10, a compact hyperspectral camera for airborne use. Specim’s new AFX10 is easy to use and can be used to check water quality, estimating the fertilizing need in agriculture, identifying vegetation species, or studying wildlife population

However, the high cost associated with the use of hyperspectral imaging and scarcity of qualified professionals is likely to hamper the growth of the market during the forecast period.

Several market players currently dominate the global hyperspectral imaging system market. The key players are engaged in product launches and strategic collaborations to strengthen their market positions.

Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/8741

Major Key Players:

Some of the Key Players in the Global Hyperspectral Imaging System Market are Headwall Photonics, Inc. (the US), Specim, Spectral Imaging Ltd. (Finland), Norsk Elektro Optikk as (NEO) (Norway), Resonon, Inc. (the US), Corning Incorporated(US), Telops (Canada), Applied Spectral Imaging(US), Bayspec, Inc.(the US), Surface Optics Corporation (US), Chemimage Corporation (US), Cubert GmbH (Germany), Raytheon (US), Galileo Group, Inc.(the US), Hypermed Imaging, Inc.(the US), Inno-Spec (Germany), Camlin Group Ltd. (UK), IMEC (Belgium), XIMEA GmbH (Germany), among others.

Segment Analysis

The Global Hyperspectral Imaging System Market has been segmented based on Product, Technology, and Application.

The market, based on product, has been divided into visible/near-infrared (VNIR), short-wave infrared (SWIR), mid-wave infrared (MWIR), long-wave infrared (LWIR). The Visible/Near-Infrared (VNIR) systems segment is likely to be the largest due to the high adoption of visible/near-infrared (VNIR) systems in various industries. The mid-wave infrared (MWIR) segment is predicted to be the fastest-growing due to increasing awareness about the rising adoption of MWIR systems in detecting volcanic vents, industrial gas leaks, or biomass burning events.

The global hyperspectral imaging system market has been segmented, based on the technology, into push broom, snapshot, and hyperspectral imaging camera others. The push broom segment is anticipated to be the largest segment during the forecast period due to the rising popularity of these devices owing to the simplified illumination requirements, minimized illumination exposure, high spectral resolution, and heat load, and the shorter capturing time.

The applications segment of the global hyperspectral imaging system market surveillance, remote sensing, machine vision/optical, and medical diagnostics. The surveillance segment is likely to hold the maximum share during the forecast period due to the rising adoption of innovative technologies in the defense sector.

Regional Analysis

The Market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas held the maximum share in the year 2018, owing to the presence of established key players in countries such as the US and Canada. The hyperspectral imaging system market in the Americas has further been categorized into North America and Latin America, with the North American market further divided into the US and Canada. The European hyperspectral imaging system market has been categorized as Western Europe and Eastern Europe. The Western European market has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hyperspectral imaging system market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hyperspectral imaging system market in this region is anticipated to be the fastest growing during the assessment period due to the rising mining activities, and blooming healthcare, agriculture, and biotechnology sector in the region. The hyperspectral imaging system market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Full Report@ https://www.marketresearchfuture.com/reports/hyperspectral-imaging-system-market-8741

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Peripheral Neuropathy Treatment Market - Global Industry Size, Share, Analysis and Forecast 2022 – 2030

Peripheral Neuropathy Treatment Market

The Peripheral Neuropathy Market is expected to reach USD 7,250 Million by 2030 at 9.1% CAGR during the forecast period 2022-2030.

The extensive study for diabetic peripheral neuropathy epidemiology to discover economic treatment and expansion of peripheral nerve repair devices market can aid the peripheral neuropathy market size to increase by 2030. Damaged nerves in hands, arms, and feet due to causes, such as; chemotherapy treatments and diabetes require immediate attention. The increase in awareness about peripheral neuropathy and its therapy are innovations in the field can add impetus to the market.

Major Key Players:

Bristol Myers Squibb (US), Novartis AG (UK), Abbott Laboratories (US), Pfizer Inc (US), Merck and Co. Inc. (US), GlaxoSmithKline plc (UK), F. Hoffmann-La Roche Ltd. (UK), Eli Lilly and Company (US), Cipla Limited (India), Lupin Limited (India), RxFunction, Inc. (US), and Dr. Reddy's Laboratories (India) among others are some key players that are studied by MRFR for the global peripheral neuropathy market study.

Segment Analysis

The segment evaluation of the global Peripheral Neuropathy Market is based on end user, type, and treatment.

The type-based segments of the peripheral neuropathy market are idiopathic peripheral neuropathy, diabetic peripheral neuropathy (DPN), HIV/AIDS-associated peripheral neuropathy, and chemotherapy-induced peripheral neuropathy (CIPN). The segment of diabetic peripheral neuropathy (DPN) can surge as the prevalence of diabetic peripheral neuropathy among the youth with diabetes populace is observed to increase. Top-notch institutes are experimenting with safety and efficacy of latest chemotherapy-induced peripheral neuropathy (CIPN) treatment solutions. chemotherapeutic agents, such as; epothilones, vinca alkaloids, platinum drugs, taxanes, lenolidamide, and bortezomib among others are used to treat CIPN. The easy availability of these natural therapeutic moiety and increase in demand for CIPN treatment to can support market progress.

The treatment-based segments of the global peripheral neuropathy market are non-pharmacological therapies, and pharmacological therapies among others. The pharmacological therapies segment is expected to hold the majority share of the market owing to the Pharmacological therapies are primary in the peripheral neuropathy therapy and the availability of different non-pharmacological therapies can favor expansion of the market in the near future.

The end users-based segments of the peripheral neuropathy market are ambulatory centers, and hospitals and clinics among others. The hospitals and clinics segment can acquire the largest share of the worldwide market. The rise in awareness about different advanced treatments introduced in hospitals and expertise can benefit the market. The ambulatory centers segment can thrive owing to the easy availability of advanced medical technology and specialized medical services.

Regional Analysis

The peripheral neuropathy market is assessed across the Americas, the Middle East & Africa, Europe, and Asia Pacific. The Americas the peripheral neuropathy market can secure the largest share of the worldwide market in the near future. The growing amount of per capita healthcare expenditure and surge in cases of peripheral neuropathy market can impact the market in the Americas. Latin America and North America are studied extensively to understand the market dynamics. The US can rise at high pace. In Europe, peripheral neuropathy market can expand exponentially due to increase in need for economic and convenient neuropathy treatment. Asia Pacific peripheral neuropathy market can surge owing to presence of top notch therapeutic companies in the region. The rise in geriatric population and diabetic patient can support expansion of the regional market. Asia Pacific can thrive in the worldwide market at rapid pace. The peripheral neuropathy market in MEA can grow at moderate pace.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Body Composition Analyzers Market – Industry Share Report 2022

Body Composition Analyzers Market

The Body Composition Analyzers Market is expected to reach USD 670.48 Million by 2030 at 8.10% CAGR during the forecast period 2022-2030.

Body composition contains three major compound water, fat mass, and muscle mass. Body composition analyzing devices are used for measuring the ratio of water, fat, and muscles in the body and recording their respective values at the point of the investigation. Body composition analyzers provide aid in analysis of increased variations in the body structure for a specific period. It has applications medical research, sports, causal association research studies in the disciplines of nutrition, anthropology, epidemiology, etc.

The growth of the global body composition analyzers market is determined by numerous factors such as increasing prevalence of metabolic disorders, technological advancements in the healthcare industry, and rising obese population. However, the increasing cost of body composition analyzers and inconsistent results are likely to hamper the growth of the global body composition analyzers market during the forecast period.

Several market players currently dominate the global body composition analyzers market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the key players in the Global Body Composition Analyzers Market are GE Healthcare Inc., Hologic Inc., Beurer GmbH, Inbody Co. Ltd., Bodystat, Cosmed S.R.L, Jawon Medical Co., Ltd, Maltron International Ltd., Omron Healthcare Inc., Seca GmbH & Co. Kg., Tanita Corporation, AccuFitness, LLC, and others.

Segment Analysis

The global body composition analyzers has been segmented based on best body composition analyzer product type, mobility, and end user.

The market, based on product type, has been divided into bioimpedance analyzer, skinfold calipers, dual-energy X-Ray absorptiometry, hydrostatic weighing equipment, air displacement plethysmography, and others. Bioimpedance analyzers are likely to hold the maximum market share in the global body composition analyzers market.

Based on mobility, body composition analyzers are divided into portable body composition analyzers and stationary body composition analyzers.

The end user segment of the market consists of hospitals, academic and research centers, fitness centers, home users, and others. The hospitals segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and undergoing medical procedures.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold the largest market share. The body composition analyzers market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada. Increasing obesity in population, rising awareness about fitness, and technological advancements in the healthcare sector are likely to provide favorable conditions for the growth of the market during forecast period.

The Asia-Pacific is anticipated to be the fastest growing market owing to the rising number of chronic disorders, well-established healthcare sectors, and increasing healthcare expenditure. The body composition analyzers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. According to the report published by International Diabetes Federation, in 2017, more than 72.94 million patients were affected by diabetes, this number represents 8.8% of the total population

The European body composition analyzers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The body composition analyzers market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

G-Protein Coupled Receptors Market 2022: Size, Share, Analysis and Forecast-2030

G-Protein Coupled Receptors Market

The G-Protein Coupled Receptors Market is expected to reach USD 3228.23 Million by 2030 at 6.8% CAGR during the forecast period 2022-2030.

GPCRs are the largest and the most diverse group of membrane receptors in eukaryotes. They are also called transmembrane domain receptors, 7TM receptors, serpentine receptor, and G protein-linked receptors. They detect molecules outside the cell and activate internal signal transduction pathways.

The growth of global G protein coupled receptors market is driven by various factors such as growing use of G protein combined receptors in medicating disclosure and advancement forms, increasing the number of drugs under clinical and preclinical studies that target these receptors. However, the high cost involved in the maintenance of GPCR cell lines is expected to curb the growth of the global G protein coupled receptor market.

Several market players currently dominate the global G protein coupled receptors market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the key players in the global G protein coupled receptor market are Thermo Fisher Scientific, Inc., Cisbio, Promega Corporation, Abcam PLC, PerkinElmer Inc., Merck Group, HD Biosciences Co., Ltd, QIAGEN, Enzo Life Sciences, and Inc.BD.

Segment Analysis

The global G protein coupled receptors market has been segmented based on the product, assay type, and application.

The market, based on product, has been divided into cell lines, detection kits, cell culture reagents, ligands, and others. The detection kits segment is likely to be the fastest during the review period as they are ready to use kits that includes all cells and reagents to perform functional GPCRs assay in live cells thus driving the growth of the global G protein coupled receptor market.

The global G protein coupled receptor market has been bifurcated, on the basis of assay type, into functional calcium assays, cAMP functional assays, cGMP assays, GTP gamma S binding assays, ß-Arrestin Functional Assays, internalization assays, and others. Calcium functional assays are the fastest segment as it has numerous advantages such as user configurability, ease in the estimation of calcium flux thus driving the growth of this segment in the GPCR market.

The global G protein coupled receptors market has been segmented, based on application into the cardiovascular system, oncology, immunology, respiratory system, central nervous system, and others. The cardiovascular system is the largest segment as angiotensin II, and β-adrenergic receptors provide therapy for a wide range of cardiovascular disease such as heart failure. Approximately 17.9 million people die each year from cardiovascular disease thus risng the growth of G protein coupled receptor market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the presence of a large number of approved drugs that target G-protein coupled receptors. The G protein coupled receptors market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European G protein coupled receptors market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The G protein coupled receptors market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The rising number of approved drugs that target GPCRs has boosted the growth of the G protein coupled receptors market, the market in Asia-Pacific is expected to be the fastest-growing. The G protein coupled receptor market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Dental Radiology and Dental Imaging Devices Market Research Report- Forecast till 2030

Dental Radiology and Dental Imaging Devices Market

The dental radiology and dental imaging devices market is anticipated to reach USD 3452.8 Million by 2030 at 7.90% CAGR during the forecast period 2022-2030.

Dental radiology and imaging devices are used for diagnosis and treatment of dental problems with the help of x-rays, radioactive substances, and other forms of radiant energy. The market is majorly driven by the technological advancements in the dental equipment, high adoption of digital dental Radiology and imaging systems, growth in aging population, and dental surgeries gaining impetus. However, high price of digital Radiology systems, and lack of reimbursement in dental care is expected to restrain the growth of this market.

There are various number of dental imaging devices present in the market. The dental Radiology and dental imaging device market is segmented by devices into dental Radiology and dental imaging. Dental radiology devices segment includes phosphor storage plates, portable x-rays, accessories, and other devices. Dental Imaging devices segment includes cameras, and dental imaging software. Demand of dental radiology and imaging devices is increasing due to an extensive use of radiology in dentistry and availability of cost effective technologies for treatment of dental problems.

Increasing demand for imaging technology in orthodontics is majorly attributed to the growth of this market as it enable better magnification and less geometric distortion, super imposed structure and varying head position. Similarly the increasing use of dental imaging techniques in endodontic due to its 3d image and better resolution is increasing the market. Also increased accuracy, less efforts and better results are another integral parts of CBCT dental imaging technique stealing the conventional methods market.

Major Key Players:

Carestream Health (U.S), Dentsply Sirona (U.S), Flow Dental (U.S), KaVo Dental GmbH (Germany), LED Medical Diagnostics Inc, (Canada), Midmark Corp. (U.S), 3M (U.S), Nobel Biocare (Part of Danaher corporation) (Switzerland) and others are some of the prominent players at the forefront of competition in the global dental radiology and dental imaging devices market and are profiled in MRFR Analysis.

Regional Analysis

Geographically, the regional dental imaging technology market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

The North America dominated the global dental radiology and dental imaging devices market with the U.S. holding the largest market share owing to numerous developments in the medical sector.

In European market is expected to exhibit positive growth during the forecast period. Whereas Asia Pacific is expected to be a growing market for Dental radiology and dental imaging devices market and expected to grow at a rapid rate. The developing countries such as China and India are leading this market due to the fast growing healthcare sector and large unmet needs over the forecast period. The Middle East & African market especially, the African region is expected to witness a poor growth owing to the lack of knowledge in medical sector, and less development in medical facilities in Middle East & Africa will have limited growth in the market.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Malocclusion Market Research Report - Global Forecast till 2030

Malocclusion Market

Malocclusion Market size is expected to reach USD 40 Billion by 2030 at 6.9% CAGR during the forecast period 2022-2030.

Malocclusion is the misalignment of teeth. Malocclusion is most often hereditary, but it can also occur due to other reasons i.e. childhood habits such as thumb sucking, pacifier use beyond age 3, and others, extra teeth or lost teeth, ill-fitting dental fillings, and jaw tumors. There are three major classes of malocclusion i.e. Class 1, Class 2, and Class 3.

Increasing prevalence of malocclusion, favorable reimbursement scenario, and rising trend of cosmetic dentistry are the key factors driving the malocclusion market.

However, lack of technological awareness and complications associated with malocclusion treatment may hinder the growth of the market to an extent. The lack of technological awareness is mainly attributed to the slow adoption rate of new technology by the dentists.

Taste the market data and market information presented through more than 296 market data tables and figures spread over 251 pages of the project report.

Major Key Players:

Some of key the players in the malocclusion market are 3M, A-dec Inc., Adenta GmbH, Align Technology, Inc, American Orthodontics, Biolase, Inc., Carestream Health, Inc., Danaher, DENTAURUM GmbH & Co. KG, Dentsply Sirona, G&H Orthodontics, Henry Schein, Inc., Midmark Corp., Patterson Companies, Inc., Planmeca OY, Rocky Mountain Orthodontics, Septodont Holding, TP Orthodontics, Inc, Ultradent Products Inc., Zimmer Dental Inc., and others.

Segment Analysis

The global malocclusion market is segmented on the basis of class, treatment, and end user.

On the basis of the class, the market is classified into class I, class II, and class III.

On the basis of the treatment, the market is segmented into orthodontic braces, surgery, and others. The orthodontic braces segment is further sub-segmented into metal braces, ceramic braces, clear aligner, and others.

On the basis of the end -users, the market is segmented into the hospital and clinics, dental clinics, and others.

Regional Analysis

The Americas dominate the malocclusion market owing to the improvement in reimbursement scenario, high healthcare expenditure, and the presence of the leading players in the region. According to the American Dental Association, in the United States, Maryland, Utah, Arkansas, and Massachusetts have the highest Medicaid FFS reimbursement rates i.e. 79.3%, 75.3%, 75.2%, and 74.1% respectively, whereas, Wisconsin, California, Washington, Maine, and Iowa have the lowest coverage relative to private dental insurance reimbursement rates.

Europe holds the second position in the malocclusion market. It is expected that the support provided by the government bodies for research & development, increasing healthcare expenditure, and rising prevalence of malocclusion are propelling the growth of the malocclusion market in the European region. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and then United Kingdom with EUR 223 billion.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.

The Middle East and Africa hold the least share of the malocclusion market owing to the presence of poor and slow developing countries, especially, in the African region.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Wednesday, December 21, 2022

Metagenomic Sequencing Market Global Synopsis, Future Scope, Top Key Players and Forecast to 2030

Metagenomic Sequencing Market

The Metagenomic Sequencing Market is anticipated to reach USD 1,659.22 Million by 2030 at 17.20% CAGR during the forecast period 2022-2030

Metagenomics sequencing, also known as environmental or community genomics is an approach that allows insight to be gained into community biodiversity and function. In the process of metagenomics sequencing, the DNA of the specified host microorganism is extracted and cloned directly from the microorganism using genetic analyses of DNA.

Currently, the metagenomic sequencing market is growing pervasively. The dominant factors driving this growth include the rising awareness of genetic disorders, advanced technological platforms, and the availability of improved genomic tools. Moreover, the continually dropping prices of this process are escalating the market on the global platform, encouraging people to undergo the genetic tests.

The function of metagenomic sequencing which is to sequence the genomes of untargeted cells in a community in order to elucidate community composition and function helps to understand the several types of cells in a community and what organisms are present in their physiology.

Research using the metagenomic sequencing taps into several fields due to the broad existence of large microbial communities. For instance; the study of soil microbiota has led to advances in understanding and treating plant pathogens. Whereas. In human gut microbiota, the use of metagenomics discovered how common antibiotic genes are in the gut bacteria.

The market demonstrates vast opportunities for service providers and companies with a great scope of expanding to enter the untapped regions by making these procedures affordable.

Additional factors fostering the growth of the market include the use of advanced bioinformatics tools, high throughput screening (HTS) methods, recovery of novel drugs, and the development of cost-effective technologies such as next-generation sequencing (NGS).

Major Key Players:

Players leading the global metagenomic sequencing market include Enterome Bioscience (France), GATC Biotech AG (Germany), Aperiomics, Inc. (U.S.), Illumina Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland), Second Genome Therapeutics (U.S.), SciGenom Labs Pvt. Ltd. (India), Quest Diagnostics Incorporated (U.S.), GenapSys, Inc. (U.S.), Freenome Inc. (U.S.), COSMOSID (U.S.), Beijing Genomics Institute (China), Pacific Biosciences (U.S.), Biomatters Ltd. (New Zealand), Oxford Nanopore Technologies Inc. (UK), Thermo Fisher Scientific Inc. (U.S.), CLC Bio (Qiagen) (Denmark), DNAStar Inc. (U.S.), Agilent Technologies Inc. (U.S.), Macrogen Inc. (South Korea), Knome Inc. (U.S.), and Helicos BioSciences (U.S.) among others.

Segment Analysis

MRFR has segmented the report into four key dynamics for an easy grasp;

By Technology: Sequencing and Bioinformatics among others.

By Application : Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Ecology, and Agriculture among others.

By End-user : Hospitals, Research Institutes, and Specialized Clinics among others.

By Regions : North America, Europe, Asia Pacific, and the Rest-of-the-World (RoW).

Regional Analysis

The North American region leads the global metagenomic sequencing market owing to the presence of global players who are focused on introducing the procedures with innovative technology. Encouraging governmental support for R&D activities in healthcare and metagenomic sequencing tests is acting as a significant tailwind that is pushing up the market.

Additional factors encouraging the growth of the market include increased uptake of advanced technologies in the next generation sequencing procedures and its increasing applications and high healthcare expenditures.

The metagenomic sequencing market in the US backed the increasing demand for metagenomic sequencing, contributes to the growth of the regional market majorly. Heading with the rising demands for metagenomic sequencing procedures, the region will create a larger revenue pocket in the global metagenomic sequencing market by 2023.

Heading with the significant advancements of technologies and their wide uptake in the medical sector, the metagenomic sequencing market in the European region holds the second position in terms of size.

Moreover, the presence of a flourishing medical devices market and rising healthcare expenditure in the region will facilitate the growth of the market. Also, factors such as support and funding from public & private sectors for research & development impacts the market growth in the region positively.

Furthermore, the availability of low-cost metagenomic and NGS procedures and their rising adoption by research laboratories are driving the growth of this market.

The Asia Pacific region heading with the increasing prevalence of genetic disorders has emerged as a promising market for metagenomic sequencing. The large unmet clinical needs are attracting the foreign investors and global players to focus on this region to expand the network that is helping them to capture major share of the market.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Sentinel Node Biopsy Market Global Demand, Growth, Top Key Players and Forecast to 2030

Sentinel Node Biopsy Market

The global sentinel node biopsy market is growing pervasively mainly due to the increasing prevalence of various types of cancer including melanoma, colon cancer, breast cancer, esophageal cancer, head and neck cancer among others. Moreover, the spreading awareness towards the advantages of sentinel node biopsy escalates its market on the global platform.

The Sentinel Node Biopsy Market is projected to reach at 4.90% CAGR during the forecast period 2022-2030.

Additional factors propelling the growth of the market include the changing lifestyle led by the growing urbanization & industrialization. Improving economic conditions worldwide are defining the growth of the sentinel node biopsy market, enabling access to the quality of life & to the improved healthcare. Furthermore, factors such as increasing number of biopsy procedures and rising demand for new techniques for the diagnosis of cancerous growth provide significant impetus to the market growth.

On the other hand, factors such as prohibitive costs associated with the biopsy and the large unmet need are some of the key factors impeding the market growth, especially in the developing nations. Nevertheless, factors such as the availability of new products and services and the presence of well-established market players in the developing as well as developed countries will support the market growth, filling up the demand and supply gap.

Major Key Players:

Key players leading the global sentinel node biopsy market include Devicor Medical Products, Inc. (Germany), C. R. Bard, Inc. (U.S.), Hilfe Engineering Corporation (India), Intramedical Imaging LLC (U.S.), KUB Technologies, Inc. (U.S.), Surgic Eye (Germany), and Navidea Biopharmaceuticals, Inc. (U.S.) among others.

Segment Analysis

The MRFR analysis is segmented into four key dynamics for enhanced understanding.

By Product : Breast Localization Wire, Tissue Marker, Gamma Probe, and Drainage Catheters, liquid biopsy among others.

By Indication: Breast Cancer, Melanoma, Colon Cancer, and Esophageal Cancer among others.

By End-user : Hospitals & Clinics, and Diagnostic Centers among others.

By Regions : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Regional Analysis

The North American region, heading with the increasing number of market players offering biopsy devices and instruments, accounts for the leading market for sentinel node biopsy, globally. Factors such as the extensive and early uptake of medical technology for advancing medical devices and the increasing governmental support for R&D activities alongside the high health care expenditures substantiate the market growth in the region.

Furthermore, the increasing number of women suffering from breast disorders and rising prevalence of breast cancer along with the availability of quality care drives the growth of the regional market. With the constant developments by companies operating in cancer diagnostics, the market is expected to create the major revenue pocket during the review period.

The sentinel node biopsies market in the European region led by the increasing emphasis on the development of advent diagnostic devices, accounts for the next largest market, globally. Moreover, factors propelling the growth of the regional market include rising government support with the increased funding for R&D activities in the field of oncology and the rising numbers of specialty services offered by various healthcare providers.

Germany leads the European sentinel node biopsies market owing to an increasing demand for cancer diagnosis. Whereas France and the U.K heading with the availability of tertiary care facilities in these countries and rising healthcare expenditures, secure second and third position, respectively.

The Asia Pacific region is emerging as a profitable market for Sentinel Node biopsies, growing rapidly. Increasing incidents of breast cancer is a key driving factor fostering market growth. Furthermore, factors such as the increasing demand for quality devices in healthcare and rapidly developing healthcare technology are fuelling the market growth in the APAC region, leading to increased use of advanced biopsy equipment.

India and China led by the presence of the highly skilled workforce and the increasing demand for biopsy procedures in hospitals and specialty care centers, exhibit enormous growth opportunities. Moreover, growing occurrences of chronic diseases, an increase in the number of women suffering for reproductive disorders, and increasing expenditure on surgical procedures in developing economies throughout the APAC foster the growth of the regional market.

About Market Research Future

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com